XTL BIOPHARMACEUTICALS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.1 ILa | -4.21% |
|
-8.08% | +160.00% |
| 04-30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-29 | Top Premarket Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 14.06M | - | - | - | - | - | |
| 58.71B | - | |||||
| 41.31B | ||||||
| 39.2B | ||||||
| 27.4B | ||||||
| 26.55B |
